Single Cell Multi-Omic Dissection of Response and Resistance to Chimeric Antigen Receptor T Cells Against BCMA in Relapsed Multiple Myeloma

被引:2
|
作者
Merz, Maximilian [1 ]
Fischer, Luise [2 ]
Sia, Jaren [3 ]
Born, Patrick [1 ]
Weiss, Ronald [2 ]
Grieb, Nora [1 ]
Rade, Michael [4 ]
Boldt, Andreas [2 ]
Fricke, Stephan [5 ]
Franz, Paul [4 ]
Scolnick, Jonathan [3 ]
Venkatraman, Lakshmi [3 ]
Xu, Stacy [3 ]
Kloetzer, Christina [1 ]
Heyn, Simone [1 ]
Kubasch, Anne Sophie [6 ]
Baber, Ronny [7 ]
Wang, Song Yau [2 ]
Bach, Enrica [1 ]
Hoffmann, Sandra [1 ]
Ussmann, Jule [1 ]
Metzeler, Klaus H. [1 ]
Herling, Marco [1 ]
Herling, Carmen [1 ]
Jentzsch, Madlen [1 ]
Franke, Georg-Nikolaus [1 ]
Sack, Ulrich [2 ]
Koehl, Ulrike [4 ]
Reiche, Kristin [4 ]
Platzbecker, Uwe [8 ]
Vucinic, Vladan [1 ]
机构
[1] Univ Leipzig, Dept Hematol Cellular Therapy Hemostaseol & Infec, Med Ctr, Leipzig, Germany
[2] Univ Leipzig, Leipzig, Germany
[3] Singleron Biotechnol, Singapore, Singapore
[4] Fraunhofer IZI, Leipzig, Germany
[5] Fraunhofer Inst Cell Therapy & Immunol IZI, Leipzig, Germany
[6] Univ Hosp Leipzig, Dept Hematol, Dresden, Germany
[7] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Med Ctr, Leipzig, Germany
[8] Univ Hosp Leipzig, Dept Hematol, Leipzig, Germany
关键词
D O I
10.1182/blood-2023-187371
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Naoki Hosen
    International Journal of Hematology, 2020, 111 : 530 - 534
  • [42] Subsequent anti-myeloma therapy after maturation antigen (BCMA) chimeric antigen receptor (CAR)-T cell (HDS269B) treatment in patients with relapsed/refractory multiple myeloma
    Chen, Dongjian
    Wang, Xiaoxiang
    Chen, Zhi
    Jiang, Songfu
    Jiang, Hua
    Fu, Weijun
    Xiang, Fang
    Sun, Xuedong
    Du, Juan
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) : E478 - E481
  • [43] OVERALL RESPONSE AND COMPLETE RESPONSE WITH ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM) : A SYSTEMATIC REVIEW AND META-ANALYSIS
    Aggarwal, S.
    Bela, A.
    Topaloglu, O.
    VALUE IN HEALTH, 2020, 23 : S25 - S25
  • [44] Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China
    Wang, Baiyan
    Liu, Jie
    Zhao, Wan-Hong
    Chen, Yin-Xia
    Cao, Xing-Mei
    Yang, Yun
    Zhang, Yi-Lin
    Wang, Fang-Xia
    Zhang, Peng-Yu
    Lei, Bo
    Gu, Liu-Fang
    Wang, Jian-Li
    Fan, Frank Xiao-Hu
    Zhang, Wang-Gang
    He, Ai-Li
    BLOOD, 2020, 136
  • [45] Case Report: Reversible Neurotoxicity and a Clinical Response Induced by BCMA-Directed Chimeric Antigen Receptor T Cells Against Multiple Myeloma With Central Nervous System Involvement
    Zhang, Ying
    Zhang, Changfeng
    Zhou, Jin
    Zhang, Jingren
    Chen, Xiaochen
    Chen, Jia
    Wang, Pu
    Sun, Xiuli
    Lou, Xiaoyan
    Qi, Wei
    Kang, Liqing
    Yu, Lei
    Wu, Depei
    Li, Caixia
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [46] Gamma secretase inhibition increases recognition of multiple myeloma by BCMA-specific chimeric antigen receptor modified T cells
    Hill, Tyler
    Pont, Margot
    Abbott, Joe
    Kelliher, Jessica
    Salter, Alexander
    Liu, Steven
    Green, Damian
    Riddell, Stanley
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [47] Prophylaxis and Vaccinations for Infections with BCMA Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma: Usmirc Practice Patterns
    Kamboj, Ishita
    Snyder, Jordan
    Gorsline, Chelsea
    Ince, Dilek
    Majeed, Aneela
    Anwer, Faiz
    Shaikh, Hira
    Khan, Abdullah Mohammad
    Abdallah, Al-Ola
    Green, Kimberly M.
    Atrash, Shebli
    Tiger, Claire Yun Kyoung Ryu
    Mewawalla, Prerna
    Paul, Barry
    Ahmed, Nausheen
    BLOOD, 2024, 144 : 5040 - 5041
  • [48] Outcomes Multiple Myeloma Patients Progressing after BCMA-Directed Chimeric Antigen Receptor T Cell (CART) Therapy
    Soomro, Mohammad Ahsen
    Atrash, Shebli
    Rashid, Aliya
    Wesson, William
    Hashmi, Hamza
    Afrough, Aimaz
    Skikne, Barry S.
    Lutfi, Forat
    Mushtaq, Muhammad Umair
    Abdallah, Al-Ola
    Ahmed, Nausheen
    BLOOD, 2023, 142
  • [49] CARDIAC EVENTS AFTER ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR T-CELL (IDECABTAGENE VICLEUCEL) FOR MULTIPLE MYELOMA
    Lee, Dae Hyun
    Chandrasekhar, Sanjay Amrith
    Jain, Michael
    Hansen, Doris
    Freeman, Ciara
    Alsina, Melissa
    Baz, Rachid
    Puglianini, Omar Castaneda
    Liu, Hien
    Blue, Brandon
    Davila, Marco L.
    Faramand, Rawan
    Kumar, Abhishek
    Shah, Bijal
    Lazaryan, Aleksandr
    Khimani, Farhad
    Nishihori, Taiga
    Bachmeier, Christina
    Locke, Frederick
    Oliveira, Guilherme Henrique
    Alomar, Mohammed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1933 - 1933
  • [50] Single Cell Multi-Omic Profiling of Multiple Myeloma with t(4;14) Identifies a T-Cell Population That Correlates with Clinical Outcomes
    de Mel, Sanjay
    Scolnick, Jonathan Adam
    Yong, Chern Han
    Xu, Stacy
    Soekojo, Cinnie Yentia
    Song, Fangfang
    Ooi, Melissa
    Chng, Wee Joo
    BLOOD, 2022, 140 : 4336 - 4337